| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.001 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |